Where Does 22nd Century Group Inc (XXII) Stock Fall in the Drug Manufacturers - Specialty & Generic Field After It Is Down -17.42% This Week?

A rating of 63 puts 22nd Century Group Inc (XXII) near the middle of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. 22nd Century Group Inc's score of 63 means it scores higher than 63% of stocks in the industry. 22nd Century Group Inc also received an overall rating of 44, putting it above 44% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 111 out of the 148 industries.

XXII has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on XXII!

See Full XXII Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 44 would rank higher than 44 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With 22nd Century Group Inc Stock Today?

22nd Century Group Inc (XXII) stock has fallen -2.68% while the S&P 500 is up 0.17% as of 1:27 PM on Friday, Sep 22. XXII is down -$0.03 from the previous closing price of $1.12 on volume of 215,077 shares. Over the past year the S&P 500 has risen 15.42% while XXII is down -92.69%. XXII lost -$5.41 per share the over the last 12 months. Click Here to get the full Stock Report for 22nd Century Group Inc stock.